European Commission grants marketing approval to Biogen's ALS drug

Biogen (BIIB.O), opens new tab said on Thursday that the European Commission has granted marketing authorization under exceptional circumstances for its amyotrophic lateral sclerosis (ALS) drug Qalsody.